nifedipine has been researched along with 17 alpha-hydroxyprogesterone caproate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Loi, K; Tan, KT | 1 |
Chawanpaiboon, S; Pimol, K; Sirisomboon, R | 1 |
King, AS; Omar, SZ; Tan, PC; Vallikkannu, N | 1 |
1 review(s) available for nifedipine and 17 alpha-hydroxyprogesterone caproate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for nifedipine and 17 alpha-hydroxyprogesterone caproate
Article | Year |
---|---|
Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Adult; Bed Rest; Delayed-Action Preparations; Female; Humans; Hydroxyprogesterones; Middle Aged; Nifedipine; Obstetric Labor, Premature; Pregnancy; Progesterone Congeners; Time Factors; Tocolytic Agents; Uterine Contraction; Young Adult | 2011 |
Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adrenal Cortex Hormones; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Progestins; Tocolytic Agents; Treatment Outcome; Young Adult | 2012 |
2 other study(ies) available for nifedipine and 17 alpha-hydroxyprogesterone caproate
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Massive pre-placental and subchorionic haematoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Female; Fetal Membranes, Premature Rupture; Hematoma; Humans; Hydroxyprogesterones; Nifedipine; Placenta Diseases; Pregnancy; Pregnancy Outcome; Progestins; Thrombosis; Tocolytic Agents; Ultrasonography; Uterine Hemorrhage | 2006 |